Press Release: InterVenn : InterVenn Demonstrates Power of Its GlycoVision Platform In Advanced Adenoma and Colorectal Cancer
Data Illustrative of the Biology Occurring in the Colonic Crypt Shows Promise for a New Modality in Pre-Cancer Detection SOUTH SAN FRANCISCO, Calif.--(BUSINESS...
Read full article »
InterVenn is a California-based AI glycoproteomics platform that offers solutions such as biomarker research and liquid biopsy assay development for the healthcare industry.
Read more